分化型甲状腺癌手术核心结局指标集:国际德尔菲共识
针对分化型甲状腺癌(DTC)手术结局选择与报告缺乏国际共识的问题,通过文献综述、两轮国际德尔菲流程及专家小组会议制定核心结局指标集(COS)。125名专家和7名患者代表参与,最终确定13项核心结局,涵盖复发、持续疾病、并发症及生活质量等。
要点
- DTC手术核心结局指标集包含13项结局,需在临床实践和未来研究中测量报告。
- 共识采用两轮德尔菲法,共识标准为两组均≥70%评分7-9或一组≥90%。
- 核心结局包括复发、持续疾病、术后甲状腺球蛋白、永久性喉返神经麻痹等。
核心结论
- 国际共识制定了DTC手术核心结局指标集,共13项结局被批准用于临床实践和研究。
研究设计与样本
- 通过文献综述收集初始结局列表,进行两轮国际德尔菲流程(专家和患者代表),最后召开国际专家小组会议定稿。
- 125名专家和7名患者代表来自35个国家、5个大洲,完成了所有轮次。
主要发现
- 两轮德尔菲后,17项结局达成共识,其中13项在专家小组会议上获批。
关键数值与推荐
- 共识纳入标准:两个利益相关组中≥70%参与者评分7-9,或一组中≥90%评分7-9。
- 共识排除标准:两组中≥70%参与者评分1-3。
- 获批的13项结局:复发、持续疾病、转移淋巴结位置、 retrieved metastatic lymph nodes数目、术后甲状腺球蛋白水平、手术完整性、手术导致的永久性喉返神经麻痹、永久性术后甲状旁腺功能减退、30天术后并发症率、术中意外邻近器官损伤、非计划再手术率、30天术后死亡率、生活质量。
临床怎么用
- 临床实践和未来研究应统一测量和报告这13项核心结局,以促进结果比较和指南形成。
局限性
- 未来需对部分结局进行定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: No international consensus exists on the selection and reporting of outcomes after differentiated thyroid cancer (DTC) surgery, hindering assessment of new treatments and guideline formation. Therefore, we aimed to develop an international core outcome set (COS) to be measured and reported in future studies investigating surgical treatment for DTC, as well as in clinical practice. Methods: COS development consisted of three phases: (1) collecting an initial outcome list through a literature review, (2) a two-round international Delphi process with experts and patient representatives, and (3) international expert panel meeting to finalize the COS. A steering committee including experts from varying medical (sub-)specialties and a patient representative from the Dutch Thyroid Patient Organization advised on the study protocol, Delphi rounds, and expert panel meeting. Experts were identified through scientific associations, international guidelines on DTC, ClinicalTrials.gov, and last authors of key studies and suggestions from the steering committee. The outcomes from the literature review were presented in successive rounds to experts and patient representatives to assess their importance for inclusion in the DTC surgical COS. Delphi results were analyzed for each stakeholder group on a 1-9 Likert scale. Consensus-in was defined as 70% or more of participants in both stakeholder groups rating the outcome 7-9 or 90% in one group. Consensus-out was defined as 70% or more in both groups rating the outcome 1-3. Consensus-out required agreement across both groups. Results: A total of 125 experts and 7 patient representatives from 35 countries across 5 continents completed all rounds. After two rounds, consensus was reached for 17 outcomes. Of these, 13 outcomes were ratified during the expert panel meeting: recurrence, persistent disease, location of metastatic lymph nodes, number of retrieved metastatic lymph nodes, postoperative thyroglobulin levels, surgical completeness, permanent recurrent laryngeal nerve paralysis due to surgery, permanent postoperative hypoparathyroidism, 30-day postoperative complication rate, accidental intraoperative injury to adjacent organ, unplanned reoperation rate, 30-day postoperative mortality, and quality of life. Conclusions: This international consensus on the COS for DTC surgery promotes consistent and appropriate outcome selection in clinical practice and research and may be incorporated into future study designs. Future steps include defining some outcomes.
引用
- van de Berg DJ, Vriens MR, van Santen HM, et al. Core Outcome Set of the Surgical Treatment of Differentiated Thyroid Carcinoma: International Consensus by Delphi Study. Thyroid. 2025. PMID: 41203254. doi:10.1177/10507256251390871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。